Dermavant Sciences Competitors and Similar CompaniesClear all

Dermavant Sciences's competitors and similar companies include aTyr Pharma, Sorrento Therapeutics and scPharmaceuticals.

	Dermavant Sciences Dermavant Sciences, a clinical-stage biopharmaceutical company, develops and commercializes therapeutics in medical dermatology.	aTyr Pharma aTyr Pharma discovers and develops protein biologics for human therapeutics.	Sorrento Therapeutics Sorrento Therapeutics is focused on the development of proprietary drug therapeutics for addressing unmet medical needs.	scPharmaceuticals scPharmaceuticals, a biopharmaceutical company, develops a portfolio of transformative pharmaceutical products for subcutaneous delivery.
Founding Date	Founding Date 2016	Founding Date 2005	Founding Date 2006	Founding Date 2014
Type	Type Subsidiary	Type Public	Type Public	Type Public
Tags	Tags Healthcare biotech healthtech pharma	Tags Healthcare biotech healthtech pharma	Tags Healthcare biotech healthtech pharma	Tags Healthcare biotech healthtech pharma
Locations	Locations Long Beach, US HQ Basel, CH Durham, US Morrisville, US New York, US Phoenix, US	Locations San Diego, US HQ	Locations San Diego, US HQ San Diego, US	Locations Burlington, US HQ
Employees	Employees 2228% decrease	Employees 4235% decrease	Employees 31019% decrease	Employees 96256% increase
Valuation ($)	Valuation ($) N/A	Valuation ($) 131.1 m	Valuation ($) 1.5 m	Valuation ($) 221.6 m
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $190k (FY, 2025)	Revenue (est.) $62.8m (FY, 2022)	Revenue (est.) $36.3m (FY, 2024)
Net income	Net income ($255.3m) (FY, 2019)	Net income ($74.1m) (FY, 2025)	Net income ($577.8m) (FY, 2022)	Net income ($85.1m) (FY, 2024)
Funding
Total funding raised	Total funding raised $ 200m	Total funding raised N/A	Total funding raised $ 42.6m	Total funding raised $ 62.5m